BiomoleculesMolecular BiologyPeer-reviewed journal article
Fibroblast-specific protein-protein interactions for myocardial fibrosis from MetaCore network
Klaus M. FrahmiD, Ekaterina A. KotelnikovaiD, Oksana KunduzovaiD, Dima L. ShepelyanskyiD
Abstract
Myocardial fibrosis is a major pathologic disorder associated with a multitude of cardiovascular diseases (CVD). The pathogenesis is complex and encompasses multiple molecular pathways. Integration of fibrosis-associated genes into the global MetaCore network of protein-protein interactions (PPI) offers opportunities to identify PPI with functional and therapeutic significance. Here, we report the generation of a fibrosis-focused PPI network and identification of fibroblast-specific PPI driving reparative and reactive myocardial fibrosis. In TGFb-mediated fibroblast activation, PPI hubs predict new regulatory mechanisms for fibrosis-associated genes. We introduce an efficient Erdos barrage approach to suppress activation of a number of fibrosis-associated nodes in order to reverse fibrotic cascades. Our results suggest that PPI prediction model can offer network insights into fibrosis mechanisms and can complement future experimental efforts to counteract cardiac fibrosis.
- organism: human
- assay: protein sequence
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: protein structure prediction
- approach: statistical model
- Citations
- 3
- FWCI
- 0.90
- Field percentile
- top 21%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Fibrosis protein-protein interactions from Google matrix analysis of MetaCore network
Ekaterina A. Kotelnikova, Klaus M. Frahm, … Oksana Kunduzova·International Journal of Molecular SciencesPeer-reviewed·Dec 22, 2021
- Logic-based mechanistic machine learning on high-content images reveals how drugs differentially regulate cardiac fibroblasts
Anders R. Nelson, Steven L. M. Christiansen, … Jeffrey J. Saucerman·Proceedings of the National Academy of SciencesPeer-reviewed·Jan 24, 2024
- Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure
J. M. Amrute, X. Luo, … K. Lavine·bioRxiv·Oct 17, 2022
- Circuit to target approach defines an autocrine myofibroblast loop that drives cardiac fibrosis
Shoval Miyara, Miri Adler, … Eldad Tzahor·Cell SystemsPeer-reviewed·Feb 18, 2025
- Interleukin 11-induced microRNAs as functional mediators and circulating biomarkers of cardiac fibrosis
Roman Tikhomirov, Veronika Boichenko, … Julia Gorelik·Circulation ResearchPeer-reviewed·Mar 17, 2026
- The dual PPAR-α/δ agonist elafibranor attenuates TGF-β1-induced cardiac fibrosis through redox-metabolic and bioenergetic reprogramming in human cardiac models
Milena Paw, Lukas Minder, … Gabriela Kania·bioRxiv·Aug 21, 2026